VRNA VERONA PHARMA PLC

Ownership history in ASSETMARK, INC  ·  4 quarters on record

This page tracks every 13F SEC filing in which ASSETMARK, INC reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 93 0% 0.00% $10K
2025 Q2 UNCHANGED 93 0% 0.00% $9K
2025 Q1 UNCHANGED 93 0% 0.00% $6K
2024 Q4 INITIATED 93 0.00% $4K
% of Fund (quarterly)
← Back to ASSETMARK, INC Holdings